#import licences

1 story

#ba-be studies #bioavailability #bioequivalence #clinical trials #drug approvals #drugs technical advisory board #generic drugs #india #pharmaceutical regulations

India eases drug approval rules for generic manufacturers
New regulations will speed up bioequivalence studies and cut import licence processing times in half.
The Economic Times · 1m